Compare MITQ & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MITQ | SNOA |
|---|---|---|
| Founded | N/A | 1999 |
| Country | United States | United States |
| Employees | 25 | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2M | 6.1M |
| IPO Year | 2019 | 2006 |
| Metric | MITQ | SNOA |
|---|---|---|
| Price | $0.52 | $1.19 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 44.4K | 38.9K |
| Earning Date | 11-13-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 70.00 | 32.26 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $20,139,000.00 | $19,529,000.00 |
| Revenue This Year | N/A | $22.44 |
| Revenue Next Year | N/A | $12.73 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 36.68 |
| 52 Week Low | $0.42 | $0.85 |
| 52 Week High | $1.00 | $4.01 |
| Indicator | MITQ | SNOA |
|---|---|---|
| Relative Strength Index (RSI) | 41.38 | 49.27 |
| Support Level | $0.52 | $1.03 |
| Resistance Level | $0.66 | $1.29 |
| Average True Range (ATR) | 0.04 | 0.06 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 10.34 | 42.11 |
Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management. It provides products, integrated systems design, custom engineering, proprietary products, software, and installation services for cinemas, screening rooms, postproduction facilities, high-end home theaters, stadiums, and other entertainment spaces. It also distributes and integrates cinema equipment from Barco, Sharp (NEC) Digital Cinema, Christie Digital, LEA Professional, Dolby, GDC, JBL/Crown, and Others.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.